FONAR Corporation (FONR) has a MoatMap StockRank of 91/100 based on Quality (62/100), Value (50/100), and Momentum (67/100) factor scores. The current signal is STRONG BUY. FONAR is a micro-cap medical equipment company specializing in upright MRI scanners. It lacks the scale, liquidity, and structural moat required for our concentrated portfolio, with no alignment to our 18-month macro themes.
FONAR Corporation designs, manufactures, and sells MRI scanners, specializing in its patented Upright® MRI technology, which allows patients to be scanned in weight-bearing positions. This unique capability provides a distinct diagnostic advantage for specific conditions, particularly spine and joint issues, that traditional recumbent MRI cannot address. FONAR also operates diagnostic imaging centers, solidifying its niche as a pioneer in patient-friendly diagnostic imaging.
| Price | $19.09 |
| Market Cap | $120M |
| P/E (TTM) | 19.09 |
| Price/Book | 0.71 |
| Return on Equity | 5.5% |
| Return on Invested Capital | 6.9% |
| Debt/Equity | 23.61 |
| Gross Margin | 40.3% |
| Operating Margin | 9.2% |
| Revenue Growth | -2.6% |
| Free Cash Flow | $1M |
FONAR Corporation operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).